In a study involving initial and secondary resected glioma specimens from 16 GBM patients, PD-1 but not PD-L1 expression was positively associated with long progression-free survival (PFS) (P = 0.029) in initial resected specimens. This evidence concerns the gene PDCD1 and central nervous system cancer.